Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

Reduced renal length and volume 20 years after very preterm birth.

Keijzer-Veen MG, Devos AS, Meradji M, Dekker FW, Nauta J, van der Heijden BJ.

Pediatr Nephrol. 2010 Mar;25(3):499-507. doi: 10.1007/s00467-009-1371-y. Epub 2009 Dec 16.

2.

Very preterm birth is a risk factor for increased systolic blood pressure at a young adult age.

Keijzer-Veen MG, Dülger A, Dekker FW, Nauta J, van der Heijden BJ.

Pediatr Nephrol. 2010 Mar;25(3):509-16. doi: 10.1007/s00467-009-1373-9. Epub 2009 Dec 15.

3.

Antenatal glucocorticoid treatment is not associated with long-term metabolic risks in individuals born before 32 weeks of gestation.

Finken MJ, Keijzer-Veen MG, Dekker FW, Frölich M, Walther FJ, Romijn JA, van der Heijden BJ, Wit JM; Dutch POPS-19 Collaborative Study Group.

Arch Dis Child Fetal Neonatal Ed. 2008 Nov;93(6):F442-7. doi: 10.1136/adc.2007.128470. Epub 2008 May 1.

PMID:
18450806
4.

Renal function and size at young adult age after intrauterine growth restriction and very premature birth.

Keijzer-Veen MG, Kleinveld HA, Lequin MH, Dekker FW, Nauta J, de Rijke YB, van der Heijden BJ.

Am J Kidney Dis. 2007 Oct;50(4):542-51.

PMID:
17900453
5.

Is nephrocalcinosis in preterm neonates harmful for long-term blood pressure and renal function?

Kist-van Holthe JE, van Zwieten PH, Schell-Feith EA, Zonderland HM, Holscher HC, Wolterbeek R, Veen S, Frolich M, van der Heijden BJ.

Pediatrics. 2007 Mar;119(3):468-75. Erratum in: Pediatrics. 2008 Jan;121(1):227.

PMID:
17332199
6.

Does citrate prevent nephrocalcinosis in preterm neonates?

Schell-Feith EA, Moerdijk A, van Zwieten PH, Zonderland HM, Holscher HC, Kist-van Holthe J, van der Heijden BJ.

Pediatr Nephrol. 2006 Dec;21(12):1830-6. Epub 2006 Oct 13.

PMID:
17039333
7.

Microalbuminuria and lower glomerular filtration rate at young adult age in subjects born very premature and after intrauterine growth retardation.

Keijzer-Veen MG, Schrevel M, Finken MJ, Dekker FW, Nauta J, Hille ET, Frölich M, van der Heijden BJ; Dutch POPS-19 Collaborative Study Group.

J Am Soc Nephrol. 2005 Sep;16(9):2762-8. Epub 2005 Jun 29.

8.

Renal replacement therapy in children: data from 12 registries in Europe.

van der Heijden BJ, van Dijk PC, Verrier-Jones K, Jager KJ, Briggs JD.

Pediatr Nephrol. 2004 Feb;19(2):213-21. Epub 2003 Dec 18.

PMID:
14685843
9.

Preterm neonates with nephrocalcinosis: natural course and renal function.

Schell-Feith EA, Kist-van Holthe JE, van Zwieten PH, Zonderland HM, Holscher HC, Swinkels DW, Brand R, Berger HM, van der Heijden BJ.

Pediatr Nephrol. 2003 Nov;18(11):1102-8. Epub 2003 Oct 2.

PMID:
14523633
10.

Prospective study of renal insufficiency after bone marrow transplantation.

Kist-van Holthe JE, Goedvolk CA, Brand R, van Weel MH, Bredius RG, van Oostayen JA, Vossen JM, van der Heijden BJ.

Pediatr Nephrol. 2002 Dec;17(12):1032-7. Epub 2002 Nov 14.

PMID:
12478353
11.

Modulation of calcium oxalate monohydrate crystallization kinetics by urine of preterm neonates.

Schell-Feith EA, Que I, Kok DJ, Kist-Van Holthe JE, Kühler E, Brand R, Papapoulos SE, van der Heijden BJ.

Am J Kidney Dis. 2001 Dec;38(6):1229-34.

PMID:
11728954
12.

Etiology of nephrocalcinosis in preterm neonates: association of nutritional intake and urinary parameters.

Schell-Feith EA, Kist-van Holthe JE, Conneman N, van Zwieten PH, Holscher HC, Zonderland HM, Brand R, van der Heijden BJ.

Kidney Int. 2000 Nov;58(5):2102-10.

13.

Ceftazidime pharmacokinetics in preterm infants: effects of renal function and gestational age.

van den Anker JN, Schoemaker RC, Hop WC, van der Heijden BJ, Weber A, Sauer PJ, Neijens HJ, de Groot R.

Clin Pharmacol Ther. 1995 Dec;58(6):650-9.

PMID:
8529330
14.

Assessment of glomerular filtration rate in preterm infants by serum creatinine: comparison with inulin clearance.

van den Anker JN, de Groot R, Broerse HM, Sauer PJ, van der Heijden BJ, Hop WC, Lindemans J.

Pediatrics. 1995 Dec;96(6):1156-8. No abstract available.

PMID:
7491242
15.

Ceftazidime pharmacokinetics in preterm infants: effect of postnatal age and postnatal exposure to indomethacin.

van den Anker JN, Hop WC, Schoemaker RC, van der Heijden BJ, Neijens HJ, de Groot R.

Br J Clin Pharmacol. 1995 Nov;40(5):439-43.

16.

The effect of asphyxia on the pharmacokinetics of ceftazidime in the term newborn.

Van Den Anker JN, Van Der Heijden BJ, Hop WC, Schoemaker RC, Broerse HM, Neijens HJ, De Groot R.

Pediatr Res. 1995 Nov;38(5):808-11.

PMID:
8552453
17.

Once-daily versus twice-daily administration of ceftazidime in the preterm infant.

van den Anker JN, Schoemaker RC, van der Heijden BJ, Broerse HM, Neijens HJ, de Groot R.

Antimicrob Agents Chemother. 1995 Sep;39(9):2048-50.

18.

Effects of prenatal exposure to betamethasone and indomethacin on the glomerular filtration rate in the preterm infant.

van den Anker JN, Hop WC, de Groot R, van der Heijden BJ, Broerse HM, Lindemans J, Sauer PJ.

Pediatr Res. 1994 Nov;36(5):578-81.

PMID:
7877874
19.

Persistent anuria, neonatal death, and renal microcystic lesions after prenatal exposure to indomethacin.

van der Heijden BJ, Carlus C, Narcy F, Bavoux F, Delezoide AL, Gubler MC.

Am J Obstet Gynecol. 1994 Sep;171(3):617-23.

PMID:
8092206
20.

Use of antibiotics in neonates weighing less than 1200 g.

van den Anker JN, de Groot R, van der Heijden BJ.

Pediatr Infect Dis J. 1990 Oct;9(10):752-3. No abstract available.

PMID:
2235153

Supplemental Content

Loading ...
Support Center